- 69038-74-0Benzoic acid, 3-bromo-,1,1-dimethylethyl ester
- 69038-81-92-Ethoxycinnamic acid
- 690-39-1Propane,1,1,1,3,3,3-hexafluoro-
- 69042-30-42,7-Naphthyridine,1-chloro-
- 69045-78-9Pyridine,2-chloro-5-(trichloromethyl)-
- 69045-79-02-Chloro-5-iodopyridine
- 69045-82-5Pyridine,2-fluoro-5-(trifluoromethyl)-
- 69045-83-6Pyridine,2,3-dichloro-5-(trichloromethyl)-
- 69045-84-72,3-Dichloro-5-trifluoromethyl pyridine
- 69046-49-7Pyridine, 4-(methyl-d)-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Creatinol phosphate |
EINECS | 230-011-8 |
| CAS No. | 6903-79-3 | Density | 1.65 g/cm3 |
| PSA | 129.68000 | LogP | -0.27900 |
| Solubility | N/A | Melting Point |
244 °C(dec.) |
| Formula | C4H12N3O4P | Boiling Point | 384.1 °C at 760 mmHg |
| Molecular Weight | 197.131 | Flash Point | 186.1 °C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Risk Codes | N/A | |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
Guanidine,1-(2-hydroxyethyl)-1-methyl-, dihydrogen phosphate (7CI);Guanidine,1-(2-hydroxyethyl)-1-methyl-, dihydrogen phosphate (ester) (8CI);2-(1-Methylguanidino)ethyl phosphate;Aplodan;Creatinol O-phosphate;Creatinolphosphate;Creatinolfosfate;N-Methyl-N-(b-hydroxyethyl)guanidine O-phosphate;O-Phosphate ofN-methyl-N-(b-hydroxyethyl)guanidine; |
Article Data | 7 |
Creatinol phosphate Synthetic route
- 6903-79-3
Aplodan
| Conditions | Yield |
|---|---|
| With water at 90℃; for 5h; |
Creatinol phosphate Chemical Properties
.jpg)
IUPAC Name: 2-[Carbamimidoyl(methyl)amino]ethyl dihydrogen phosphate
Molecular Weight: 197.129541 [g/mol]
Molecular Formula: C4H12N3O4P
XLogP3-AA: -2.5
H-Bond Donor: 4
H-Bond Acceptor: 7
EINECS: 230-011-8
Index of Refraction: 1.574
Molar Refractivity: 39.37 cm3
Molar Volume: 119.1 cm3
Surface Tension: 81.5 dyne/cm
Density: 1.65 g/cm3
Flash Point: 186.1 °C
Enthalpy of Vaporization: 69.46 kJ/mol
Boiling Point: 384.1 °C at 760 mmHg
Vapour Pressure: 5.78E-07 mmHg at 25 °C
Classification Code of Guanidine,N-methyl-N-[2-(phosphonooxy)ethyl]- (CAS NO.6903-79-3): Drug / Therapeutic Agent
Creatinol phosphate Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| guinea pig | LD50 | intraperitoneal | 3200mg/kg (3200mg/kg) | PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA | Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979. |
| guinea pig | LD50 | intravenous | 1500mg/kg (1500mg/kg) | PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE BEHAVIORAL: ATAXIA BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979. |
| guinea pig | LD50 | oral | > 5gm/kg (5000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979. | |
| mouse | LD50 | intraperitoneal | 3gm/kg (3000mg/kg) | PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA | Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979. |
| mouse | LD50 | intravenous | 1200mg/kg (1200mg/kg) | PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE BEHAVIORAL: ATAXIA BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979. |
| mouse | LD50 | oral | > 5gm/kg (5000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979. | |
| rat | LD50 | intraperitoneal | 4800mg/kg (4800mg/kg) | PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA | Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979. |
| rat | LD50 | intravenous | 1300mg/kg (1300mg/kg) | PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE BEHAVIORAL: ATAXIA BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979. |
| rat | LD50 | oral | > 5gm/kg (5000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979. |
Creatinol phosphate Specification
Guanidine,N-methyl-N-[2-(phosphonooxy)ethyl]- (CAS NO.6903-79-3), its Synonyms are Creatinol phosphate ; Creatinolfosfate ; 1-(2-Hydroxyethyl)-1-methylguanidine dihydrogen phosphate (ester) ; 2-(1-Methylguanidino)ethyl dihydrogenphosphat ; Aplodan ; Creatinol O-phosphate ; Creatinolfosfatum ; Gipron ; N-Methyl-N-(2-(phosphonooxy)ethyl)guanidine ; N-Methyl-N-(beta-hydroxyaethyl)guanidine-O-phosphat ; N-Methyl-N-(beta-hydroxyethyl)guanidine O-phosphate ; Nergize .
What can I do for you?
Get Best Price
